Cell and Gene Therapy Manufacturing Services Market, Global Outlook and Forecast 2022-2028
Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).
This report contains market size and forecasts of Cell and Gene Therapy Manufacturing Services in Global, including the following market information:
Global Cell and Gene Therapy Manufacturing Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell and Gene Therapy Manufacturing Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
By Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy Manufacturing Services include Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation and FUJIFILM Holdings Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell and Gene Therapy Manufacturing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Manufacturing Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Type, 2021 (%)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Application, 2021 (%)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy Manufacturing Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell and Gene Therapy Manufacturing Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Cell and Gene Therapy Manufacturing Services in Global, including the following market information:
Global Cell and Gene Therapy Manufacturing Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell and Gene Therapy Manufacturing Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
By Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy Manufacturing Services include Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation and FUJIFILM Holdings Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell and Gene Therapy Manufacturing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Manufacturing Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Type, 2021 (%)
- By Cell Therapy
- Allogeneic
- Autologous
- Viral Vector
- By Gene Therapy
- Non-viral Vector
- Oligonucleotides
- Viral Vector
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Application, 2021 (%)
- Oncology Diseases
- Cardiovascular Diseases
- Orthopedic Diseases
- Ophthalmology Diseases
- Infectious Diseases
- Others
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy Manufacturing Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell and Gene Therapy Manufacturing Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific
- Merck KGaA
- Charles River Laboratories
- Lonza
- Catalent
- WuXi AppTec
- Takara Bio Inc
- Nikon Corporation
- FUJIFILM Holdings Corporation
- F. Hoffmann-La Roche
- Oxford Biomedica Plc
- Cell and Gene Therapy Catapult
- The Discovery Labs LLC
- RoslinCT
- JRS PHARMA
- FinVector
- ABL
- Resilience
- BioCentriq
- Porton Biopharma Limited
- Andelyn Biosciences
- Commercializing Living Therapies
- Vibalogics
- Anemocyte Srl
- ElevateBio
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Cell and Gene Therapy Manufacturing Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Manufacturing Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES OVERALL MARKET SIZE
2.1 Global Cell and Gene Therapy Manufacturing Services Market Size: 2021 VS 2028
2.2 Global Cell and Gene Therapy Manufacturing Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Cell and Gene Therapy Manufacturing Services Players in Global Market
3.2 Top Global Cell and Gene Therapy Manufacturing Services Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Manufacturing Services Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Manufacturing Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell and Gene Therapy Manufacturing Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Manufacturing Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Cell and Gene Therapy Manufacturing Services Market Size Markets, 2021 & 2028
4.1.2 Allogeneic
4.1.3 Autologous
4.1.4 Viral Vector
4.2 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
4.2.2 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
4.2.3 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Manufacturing Services Market Size, 2021 & 2028
5.1.2 Oncology Diseases
5.1.3 Cardiovascular Diseases
5.1.4 Orthopedic Diseases
5.1.5 Ophthalmology Diseases
5.1.6 Infectious Diseases
5.1.7 Others
5.2 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
5.2.2 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
5.2.3 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cell and Gene Therapy Manufacturing Services Market Size, 2021 & 2028
6.2 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
6.2.2 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
6.2.3 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.3.2 US Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.3.3 Canada Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.3.4 Mexico Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.4.2 Germany Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.3 France Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.4 U.K. Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.5 Italy Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.6 Russia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.7 Nordic Countries Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.8 Benelux Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.5.2 China Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5.3 Japan Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5.4 South Korea Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5.5 Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5.6 India Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.6.2 Brazil Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.6.3 Argentina Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.7.2 Turkey Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.7.3 Israel Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.7.4 Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.7.5 UAE Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.1.4 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 Merck KGaA
7.2.1 Merck KGaA Corporate Summary
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.2.4 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.2.5 Merck KGaA Key News
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Corporate Summary
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.3.5 Charles River Laboratories Key News
7.4 Lonza
7.4.1 Lonza Corporate Summary
7.4.2 Lonza Business Overview
7.4.3 Lonza Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.4.4 Lonza Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.4.5 Lonza Key News
7.5 Catalent
7.5.1 Catalent Corporate Summary
7.5.2 Catalent Business Overview
7.5.3 Catalent Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.5.4 Catalent Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.5.5 Catalent Key News
7.6 WuXi AppTec
7.6.1 WuXi AppTec Corporate Summary
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.6.4 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.6.5 WuXi AppTec Key News
7.7 Takara Bio Inc
7.7.1 Takara Bio Inc Corporate Summary
7.7.2 Takara Bio Inc Business Overview
7.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.7.4 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.7.5 Takara Bio Inc Key News
7.8 Nikon Corporation
7.8.1 Nikon Corporation Corporate Summary
7.8.2 Nikon Corporation Business Overview
7.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.8.4 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.8.5 Nikon Corporation Key News
7.9 FUJIFILM Holdings Corporation
7.9.1 FUJIFILM Holdings Corporation Corporate Summary
7.9.2 FUJIFILM Holdings Corporation Business Overview
7.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.9.4 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.9.5 FUJIFILM Holdings Corporation Key News
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Corporate Summary
7.10.2 F. Hoffmann-La Roche Business Overview
7.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.10.4 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.10.5 F. Hoffmann-La Roche Key News
7.11 Oxford Biomedica Plc
7.11.1 Oxford Biomedica Plc Corporate Summary
7.11.2 Oxford Biomedica Plc Business Overview
7.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.11.4 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.11.5 Oxford Biomedica Plc Key News
7.12 Cell and Gene Therapy Catapult
7.12.1 Cell and Gene Therapy Catapult Corporate Summary
7.12.2 Cell and Gene Therapy Catapult Business Overview
7.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.12.4 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.12.5 Cell and Gene Therapy Catapult Key News
7.13 The Discovery Labs LLC
7.13.1 The Discovery Labs LLC Corporate Summary
7.13.2 The Discovery Labs LLC Business Overview
7.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.13.4 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.13.5 The Discovery Labs LLC Key News
7.14 RoslinCT
7.14.1 RoslinCT Corporate Summary
7.14.2 RoslinCT Business Overview
7.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.14.4 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.14.5 RoslinCT Key News
7.15 JRS PHARMA
7.15.1 JRS PHARMA Corporate Summary
7.15.2 JRS PHARMA Business Overview
7.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.15.4 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.15.5 JRS PHARMA Key News
7.16 FinVector
7.16.1 FinVector Corporate Summary
7.16.2 FinVector Business Overview
7.16.3 FinVector Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.16.4 FinVector Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.16.5 FinVector Key News
7.17 ABL
7.17.1 ABL Corporate Summary
7.17.2 ABL Business Overview
7.17.3 ABL Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.17.4 ABL Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.17.5 ABL Key News
7.18 Resilience
7.18.1 Resilience Corporate Summary
7.18.2 Resilience Business Overview
7.18.3 Resilience Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.18.4 Resilience Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.18.5 Resilience Key News
7.19 BioCentriq
7.19.1 BioCentriq Corporate Summary
7.19.2 BioCentriq Business Overview
7.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.19.4 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.19.5 BioCentriq Key News
7.20 Porton Biopharma Limited
7.20.1 Porton Biopharma Limited Corporate Summary
7.20.2 Porton Biopharma Limited Business Overview
7.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.20.4 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.20.5 Porton Biopharma Limited Key News
7.21 Andelyn Biosciences
7.21.1 Andelyn Biosciences Corporate Summary
7.21.2 Andelyn Biosciences Business Overview
7.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.21.4 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.21.5 Andelyn Biosciences Key News
7.22 Commercializing Living Therapies
7.22.1 Commercializing Living Therapies Corporate Summary
7.22.2 Commercializing Living Therapies Business Overview
7.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.22.4 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.22.5 Commercializing Living Therapies Key News
7.23 Vibalogics
7.23.1 Vibalogics Corporate Summary
7.23.2 Vibalogics Business Overview
7.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.23.4 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.23.5 Vibalogics Key News
7.24 Anemocyte Srl
7.24.1 Anemocyte Srl Corporate Summary
7.24.2 Anemocyte Srl Business Overview
7.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.24.4 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.24.5 Anemocyte Srl Key News
7.25 ElevateBio
7.25.1 ElevateBio Corporate Summary
7.25.2 ElevateBio Business Overview
7.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.25.4 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.25.5 ElevateBio Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Cell and Gene Therapy Manufacturing Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Manufacturing Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES OVERALL MARKET SIZE
2.1 Global Cell and Gene Therapy Manufacturing Services Market Size: 2021 VS 2028
2.2 Global Cell and Gene Therapy Manufacturing Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Cell and Gene Therapy Manufacturing Services Players in Global Market
3.2 Top Global Cell and Gene Therapy Manufacturing Services Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Manufacturing Services Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Manufacturing Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell and Gene Therapy Manufacturing Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Manufacturing Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Cell and Gene Therapy Manufacturing Services Market Size Markets, 2021 & 2028
4.1.2 Allogeneic
4.1.3 Autologous
4.1.4 Viral Vector
4.2 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
4.2.2 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
4.2.3 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Manufacturing Services Market Size, 2021 & 2028
5.1.2 Oncology Diseases
5.1.3 Cardiovascular Diseases
5.1.4 Orthopedic Diseases
5.1.5 Ophthalmology Diseases
5.1.6 Infectious Diseases
5.1.7 Others
5.2 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
5.2.2 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
5.2.3 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cell and Gene Therapy Manufacturing Services Market Size, 2021 & 2028
6.2 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2022
6.2.2 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue, 2023-2028
6.2.3 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.3.2 US Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.3.3 Canada Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.3.4 Mexico Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.4.2 Germany Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.3 France Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.4 U.K. Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.5 Italy Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.6 Russia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.7 Nordic Countries Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.4.8 Benelux Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.5.2 China Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5.3 Japan Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5.4 South Korea Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5.5 Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.5.6 India Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.6.2 Brazil Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.6.3 Argentina Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028
6.7.2 Turkey Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.7.3 Israel Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.7.4 Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
6.7.5 UAE Cell and Gene Therapy Manufacturing Services Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.1.4 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 Merck KGaA
7.2.1 Merck KGaA Corporate Summary
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.2.4 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.2.5 Merck KGaA Key News
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Corporate Summary
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.3.5 Charles River Laboratories Key News
7.4 Lonza
7.4.1 Lonza Corporate Summary
7.4.2 Lonza Business Overview
7.4.3 Lonza Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.4.4 Lonza Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.4.5 Lonza Key News
7.5 Catalent
7.5.1 Catalent Corporate Summary
7.5.2 Catalent Business Overview
7.5.3 Catalent Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.5.4 Catalent Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.5.5 Catalent Key News
7.6 WuXi AppTec
7.6.1 WuXi AppTec Corporate Summary
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.6.4 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.6.5 WuXi AppTec Key News
7.7 Takara Bio Inc
7.7.1 Takara Bio Inc Corporate Summary
7.7.2 Takara Bio Inc Business Overview
7.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.7.4 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.7.5 Takara Bio Inc Key News
7.8 Nikon Corporation
7.8.1 Nikon Corporation Corporate Summary
7.8.2 Nikon Corporation Business Overview
7.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.8.4 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.8.5 Nikon Corporation Key News
7.9 FUJIFILM Holdings Corporation
7.9.1 FUJIFILM Holdings Corporation Corporate Summary
7.9.2 FUJIFILM Holdings Corporation Business Overview
7.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.9.4 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.9.5 FUJIFILM Holdings Corporation Key News
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Corporate Summary
7.10.2 F. Hoffmann-La Roche Business Overview
7.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.10.4 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.10.5 F. Hoffmann-La Roche Key News
7.11 Oxford Biomedica Plc
7.11.1 Oxford Biomedica Plc Corporate Summary
7.11.2 Oxford Biomedica Plc Business Overview
7.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.11.4 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.11.5 Oxford Biomedica Plc Key News
7.12 Cell and Gene Therapy Catapult
7.12.1 Cell and Gene Therapy Catapult Corporate Summary
7.12.2 Cell and Gene Therapy Catapult Business Overview
7.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.12.4 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.12.5 Cell and Gene Therapy Catapult Key News
7.13 The Discovery Labs LLC
7.13.1 The Discovery Labs LLC Corporate Summary
7.13.2 The Discovery Labs LLC Business Overview
7.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.13.4 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.13.5 The Discovery Labs LLC Key News
7.14 RoslinCT
7.14.1 RoslinCT Corporate Summary
7.14.2 RoslinCT Business Overview
7.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.14.4 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.14.5 RoslinCT Key News
7.15 JRS PHARMA
7.15.1 JRS PHARMA Corporate Summary
7.15.2 JRS PHARMA Business Overview
7.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.15.4 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.15.5 JRS PHARMA Key News
7.16 FinVector
7.16.1 FinVector Corporate Summary
7.16.2 FinVector Business Overview
7.16.3 FinVector Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.16.4 FinVector Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.16.5 FinVector Key News
7.17 ABL
7.17.1 ABL Corporate Summary
7.17.2 ABL Business Overview
7.17.3 ABL Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.17.4 ABL Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.17.5 ABL Key News
7.18 Resilience
7.18.1 Resilience Corporate Summary
7.18.2 Resilience Business Overview
7.18.3 Resilience Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.18.4 Resilience Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.18.5 Resilience Key News
7.19 BioCentriq
7.19.1 BioCentriq Corporate Summary
7.19.2 BioCentriq Business Overview
7.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.19.4 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.19.5 BioCentriq Key News
7.20 Porton Biopharma Limited
7.20.1 Porton Biopharma Limited Corporate Summary
7.20.2 Porton Biopharma Limited Business Overview
7.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.20.4 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.20.5 Porton Biopharma Limited Key News
7.21 Andelyn Biosciences
7.21.1 Andelyn Biosciences Corporate Summary
7.21.2 Andelyn Biosciences Business Overview
7.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.21.4 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.21.5 Andelyn Biosciences Key News
7.22 Commercializing Living Therapies
7.22.1 Commercializing Living Therapies Corporate Summary
7.22.2 Commercializing Living Therapies Business Overview
7.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.22.4 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.22.5 Commercializing Living Therapies Key News
7.23 Vibalogics
7.23.1 Vibalogics Corporate Summary
7.23.2 Vibalogics Business Overview
7.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.23.4 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.23.5 Vibalogics Key News
7.24 Anemocyte Srl
7.24.1 Anemocyte Srl Corporate Summary
7.24.2 Anemocyte Srl Business Overview
7.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.24.4 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.24.5 Anemocyte Srl Key News
7.25 ElevateBio
7.25.1 ElevateBio Corporate Summary
7.25.2 ElevateBio Business Overview
7.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.25.4 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2017-2022)
7.25.5 ElevateBio Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Cell and Gene Therapy Manufacturing Services Market Opportunities & Trends in Global Market
Table 2. Cell and Gene Therapy Manufacturing Services Market Drivers in Global Market
Table 3. Cell and Gene Therapy Manufacturing Services Market Restraints in Global Market
Table 4. Key Players of Cell and Gene Therapy Manufacturing Services in Global Market
Table 5. Top Cell and Gene Therapy Manufacturing Services Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell and Gene Therapy Manufacturing Services Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell and Gene Therapy Manufacturing Services Product Type
Table 9. List of Global Tier 1 Cell and Gene Therapy Manufacturing Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offerings
Table 32. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 33. Merck KGaA Corporate Summary
Table 34. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offerings
Table 35. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 36. Charles River Laboratories Corporate Summary
Table 37. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offerings
Table 38. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 39. Lonza Corporate Summary
Table 40. Lonza Cell and Gene Therapy Manufacturing Services Product Offerings
Table 41. Lonza Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 42. Catalent Corporate Summary
Table 43. Catalent Cell and Gene Therapy Manufacturing Services Product Offerings
Table 44. Catalent Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 45. WuXi AppTec Corporate Summary
Table 46. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offerings
Table 47. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 48. Takara Bio Inc Corporate Summary
Table 49. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offerings
Table 50. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 51. Nikon Corporation Corporate Summary
Table 52. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offerings
Table 53. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 54. FUJIFILM Holdings Corporation Corporate Summary
Table 55. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offerings
Table 56. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 57. F. Hoffmann-La Roche Corporate Summary
Table 58. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offerings
Table 59. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 60. Oxford Biomedica Plc Corporate Summary
Table 61. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offerings
Table 62. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 63. Cell and Gene Therapy Catapult Corporate Summary
Table 64. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offerings
Table 65. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 66. The Discovery Labs LLC Corporate Summary
Table 67. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offerings
Table 68. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 69. RoslinCT Corporate Summary
Table 70. RoslinCT Cell and Gene Therapy Manufacturing Services Product Offerings
Table 71. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 72. JRS PHARMA Corporate Summary
Table 73. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offerings
Table 74. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 75. FinVector Corporate Summary
Table 76. FinVector Cell and Gene Therapy Manufacturing Services Product Offerings
Table 77. FinVector Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 78. ABL Corporate Summary
Table 79. ABL Cell and Gene Therapy Manufacturing Services Product Offerings
Table 80. ABL Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 81. Resilience Corporate Summary
Table 82. Resilience Cell and Gene Therapy Manufacturing Services Product Offerings
Table 83. Resilience Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 84. BioCentriq Corporate Summary
Table 85. BioCentriq Cell and Gene Therapy Manufacturing Services Product Offerings
Table 86. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 87. Porton Biopharma Limited Corporate Summary
Table 88. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offerings
Table 89. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 90. Andelyn Biosciences Corporate Summary
Table 91. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offerings
Table 92. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 93. Commercializing Living Therapies Corporate Summary
Table 94. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offerings
Table 95. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 96. Vibalogics Corporate Summary
Table 97. Vibalogics Cell and Gene Therapy Manufacturing Services Product Offerings
Table 98. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 99. Anemocyte Srl Corporate Summary
Table 100. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offerings
Table 101. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 102. ElevateBio Corporate Summary
Table 103. ElevateBio Cell and Gene Therapy Manufacturing Services Product Offerings
Table 104. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 1. Cell and Gene Therapy Manufacturing Services Market Opportunities & Trends in Global Market
Table 2. Cell and Gene Therapy Manufacturing Services Market Drivers in Global Market
Table 3. Cell and Gene Therapy Manufacturing Services Market Restraints in Global Market
Table 4. Key Players of Cell and Gene Therapy Manufacturing Services in Global Market
Table 5. Top Cell and Gene Therapy Manufacturing Services Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell and Gene Therapy Manufacturing Services Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell and Gene Therapy Manufacturing Services Product Type
Table 9. List of Global Tier 1 Cell and Gene Therapy Manufacturing Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offerings
Table 32. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 33. Merck KGaA Corporate Summary
Table 34. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offerings
Table 35. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 36. Charles River Laboratories Corporate Summary
Table 37. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offerings
Table 38. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 39. Lonza Corporate Summary
Table 40. Lonza Cell and Gene Therapy Manufacturing Services Product Offerings
Table 41. Lonza Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 42. Catalent Corporate Summary
Table 43. Catalent Cell and Gene Therapy Manufacturing Services Product Offerings
Table 44. Catalent Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 45. WuXi AppTec Corporate Summary
Table 46. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offerings
Table 47. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 48. Takara Bio Inc Corporate Summary
Table 49. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offerings
Table 50. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 51. Nikon Corporation Corporate Summary
Table 52. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offerings
Table 53. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 54. FUJIFILM Holdings Corporation Corporate Summary
Table 55. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offerings
Table 56. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 57. F. Hoffmann-La Roche Corporate Summary
Table 58. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offerings
Table 59. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 60. Oxford Biomedica Plc Corporate Summary
Table 61. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offerings
Table 62. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 63. Cell and Gene Therapy Catapult Corporate Summary
Table 64. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offerings
Table 65. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 66. The Discovery Labs LLC Corporate Summary
Table 67. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offerings
Table 68. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 69. RoslinCT Corporate Summary
Table 70. RoslinCT Cell and Gene Therapy Manufacturing Services Product Offerings
Table 71. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 72. JRS PHARMA Corporate Summary
Table 73. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offerings
Table 74. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 75. FinVector Corporate Summary
Table 76. FinVector Cell and Gene Therapy Manufacturing Services Product Offerings
Table 77. FinVector Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 78. ABL Corporate Summary
Table 79. ABL Cell and Gene Therapy Manufacturing Services Product Offerings
Table 80. ABL Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 81. Resilience Corporate Summary
Table 82. Resilience Cell and Gene Therapy Manufacturing Services Product Offerings
Table 83. Resilience Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 84. BioCentriq Corporate Summary
Table 85. BioCentriq Cell and Gene Therapy Manufacturing Services Product Offerings
Table 86. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 87. Porton Biopharma Limited Corporate Summary
Table 88. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offerings
Table 89. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 90. Andelyn Biosciences Corporate Summary
Table 91. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offerings
Table 92. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 93. Commercializing Living Therapies Corporate Summary
Table 94. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offerings
Table 95. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 96. Vibalogics Corporate Summary
Table 97. Vibalogics Cell and Gene Therapy Manufacturing Services Product Offerings
Table 98. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 99. Anemocyte Srl Corporate Summary
Table 100. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offerings
Table 101. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
Table 102. ElevateBio Corporate Summary
Table 103. ElevateBio Cell and Gene Therapy Manufacturing Services Product Offerings
Table 104. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Manufacturing Services Segment by Type in 2021
Figure 2. Cell and Gene Therapy Manufacturing Services Segment by Application in 2021
Figure 3. Global Cell and Gene Therapy Manufacturing Services Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2021
Figure 8. By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 12. US Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 16. Germany Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 24. China Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 30. Brazil Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 33. Turkey Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Lonza Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Catalent Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. FinVector Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. ABL Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Resilience Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Cell and Gene Therapy Manufacturing Services Segment by Type in 2021
Figure 2. Cell and Gene Therapy Manufacturing Services Segment by Application in 2021
Figure 3. Global Cell and Gene Therapy Manufacturing Services Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell and Gene Therapy Manufacturing Services Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2021
Figure 8. By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 12. US Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 16. Germany Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 24. China Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 30. Brazil Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2017-2028
Figure 33. Turkey Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Lonza Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Catalent Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. FinVector Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. ABL Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Resilience Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
